ABCG2 and ovarian carcinoma: Consistent with previous study, our data reveal that cholesterol alone and malignant ascites derived from ovarian cancer patients upregulates the protein expression of ABCG2 and MDR1, associated with poor prognosis and chemoresistance in ovarian cancer patients [42–44].